Histanaz Tablet
Product Images NDC 29978-129

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Histanaz (NDC 29978-129). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Capital Pharmaceutical, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (Histanaz Capital)

Label (Histanaz Capital)
Histanaz tablets label showing active ingredients Pseudoephedrine HCl 60 mg and Pyrilamine Maleate 30 mg. The label indicates it is an oral tablet product from Capital Pharmaceutical, LLC with a package of 100 tablets. Includes tamper-evident warning and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.